Enterobacteriaceae infections are caused by Enterobacter species, pathogens responsible for causing severe infections including bacteremia, urinary tract infections, lower respiratory tract infections, skin and soft tissue infections, and intra-abdominal infections.
In 2018, the global Enterobacteriaceae Infection Drug market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Enterobacteriaceae Infection Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Enterobacteriaceae Infection Drug development in North America, Europe and Asia-Pacific.

The key players covered in this study
Genentech
Nanotherapeutics
Novartis
Pfizer
Nymox Pharmaceutical
Sequoia Sciences
Phico Therapeutics
Cantab Biopharmaceuticals

Market segment by Type, the product can be split into
Beta-lactams Drugs
Carbapenems Drugs
Fluoroquinolones Drugs
Others

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
North America
Europe
Asia-Pacific

The study objectives of this report are:
To analyze global Enterobacteriaceae Infection Drug status, future forecast, growth opportunity, key market and key players.
To present the Enterobacteriaceae Infection Drug development in North America, Europe and Asia-Pacific.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Enterobacteriaceae Infection Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.